Looking to sell Pathos stock or options?
Pathos has developed a drug discovery platform designed to shorten the medication development timeline. The company's innovative platform leverages big data, technology, and artificial intelligence to identify targets, validate them, and confirm their clinical efficacy. This approach enables drug developers to explore novel ideas and advance groundbreaking therapies for cancer and other diseases.
New Enterprise Associates, Revolution Group, Eric Lefkofsky, Lightbank (Service Provider), Builders VC, Revolution (Washington DC).